GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N93020C00031GRYPHON SCIENTIFIC, LLC

Overview

Award facts

Net obligations
$3.65M
$3,646,672of $3.89M potential value
Outlays (paid to date)
$3.05M
$3.05M paid of $3.65M obligated$3,045,671
Period of performance
Sep 30, 2020 to Sep 29, 2025
Ended
Modifications
9
Latest action Jun 30, 2026
Contract type
Definitive contract
PIID 75N93020C00031

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

THE OBJECTIVE OF THIS CONTRACT IS TO PROVIDE SUPPORT FOR THE ONGOING SURVEY OF CHEMICAL AND BIOLOGICAL INFORMATION FOR POTENTIAL THERAPEUTIC COMPOUNDS FOR HIV, TB, AND HEPATITIS B VIRUS (HBV). THE RESULTING INFORMATION AND ASSOCIATED ANALYTICAL TOOLS

Dates and value

Award date
Signed on Sep 1, 2020
Current value
$3,646,672Base and exercised options
Potential value (if all options are exercised)
$3,887,150

Obligations by fiscal year of action

  • FY2026: -$1,227 (de-obligation)
  • FY2025: -$2,576 (de-obligation)
  • FY2024: $799,353
  • FY2023: $765,864
  • FY2022: $802,459
  • FY2021: $649,242
  • FY2020: $633,557

Total across 7 fiscal years: $3,646,672

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 30, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationBEVERLY, MA
UEIK9MTXN4LNUM4
CAGE code8ABT1
Business sizeSmall businessSize at award, per the contracting officer

Business types and certifications

For-profit organizationLimited liability company

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Takoma Park, Montgomery County, Maryland 20912-4481
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Sealed bidSB
Set-aside
Small business set aside - totalSBA
Contract pricing
Time and materialsY
Offers received
1

Solicitation and notices

Solicitation ID
75N93019Q00003(as reported)
Solicitation date
Jan 6, 2020

Contract details

Subcontracting plan
Plan not requiredB
Major program
Analysis of chemical structures and therapeutic activity of agents for hiv, tb, and hbv (CHEMDB)
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
Yes
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 1, 2020Base obligation at award: $633,557
Latest action
Jun 30, 2026 — Funding onlyModification P00009; obligation change -$1,227; funding only: changes obligations, not scope
Latest substantive action
Jun 23, 2023 — Option exercisedModification P00005; obligation change +$765,864
Latest funding action
Jun 30, 2026 — Funding onlyModification P00009; obligation change -$1,227; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Funding only3
  • Option exercised3
  • Other administrative action2
  • Change order1
10 actions recorded, Sep 1, 2020 to Jun 30, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$1,227
Latest action: change in base and all options
-$1,227

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2020-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
  • 075-2024/2024-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression